全文获取类型
| 收费全文 | 2270篇 |
| 免费 | 26篇 |
| 国内免费 | 1篇 |
专业分类
| 耳鼻咽喉 | 13篇 |
| 儿科学 | 65篇 |
| 妇产科学 | 41篇 |
| 基础医学 | 227篇 |
| 口腔科学 | 57篇 |
| 临床医学 | 153篇 |
| 内科学 | 524篇 |
| 皮肤病学 | 39篇 |
| 神经病学 | 136篇 |
| 特种医学 | 29篇 |
| 外科学 | 359篇 |
| 综合类 | 1篇 |
| 一般理论 | 4篇 |
| 预防医学 | 388篇 |
| 眼科学 | 34篇 |
| 药学 | 64篇 |
| 中国医学 | 8篇 |
| 肿瘤学 | 155篇 |
出版年
| 2023年 | 12篇 |
| 2022年 | 23篇 |
| 2021年 | 71篇 |
| 2020年 | 25篇 |
| 2019年 | 491篇 |
| 2018年 | 294篇 |
| 2017年 | 163篇 |
| 2016年 | 22篇 |
| 2015年 | 27篇 |
| 2014年 | 39篇 |
| 2013年 | 56篇 |
| 2012年 | 27篇 |
| 2011年 | 35篇 |
| 2010年 | 32篇 |
| 2009年 | 33篇 |
| 2008年 | 47篇 |
| 2007年 | 30篇 |
| 2006年 | 30篇 |
| 2005年 | 35篇 |
| 2004年 | 22篇 |
| 2003年 | 29篇 |
| 2002年 | 19篇 |
| 2001年 | 29篇 |
| 2000年 | 21篇 |
| 1999年 | 13篇 |
| 1998年 | 13篇 |
| 1997年 | 11篇 |
| 1996年 | 10篇 |
| 1995年 | 14篇 |
| 1994年 | 10篇 |
| 1993年 | 12篇 |
| 1992年 | 12篇 |
| 1991年 | 7篇 |
| 1990年 | 4篇 |
| 1989年 | 5篇 |
| 1988年 | 8篇 |
| 1987年 | 3篇 |
| 1985年 | 62篇 |
| 1984年 | 107篇 |
| 1983年 | 69篇 |
| 1982年 | 71篇 |
| 1981年 | 55篇 |
| 1980年 | 56篇 |
| 1979年 | 51篇 |
| 1978年 | 24篇 |
| 1977年 | 16篇 |
| 1976年 | 20篇 |
| 1975年 | 14篇 |
| 1974年 | 10篇 |
| 1973年 | 7篇 |
排序方式： 共有2297条查询结果，搜索用时 31 毫秒
1.
2.
F. Giovanardi F. Nudo Q. Lai M. Garofalo A. Consolo E. Choppin De Janvry G.A. Arroyo Murillo P. Ursi D. Stabile F. Melandro P.B. Berloco R. Pretagostini L. Poli 《Transplantation proceedings》2019,51(1):128-131
Background
Arterial vascular anomalies in patients undergoing kidney transplantation (KT) are correlated with a higher incidence of early surgical complications, potentially causing graft loss. Arterial reconstruction allows patients to overcome these surgical challenges, thus minimizing the risk of poor outcomes. The aim of the present study is to retrospectively investigate the safety and effectiveness of the multiple arterial reconstruction technique with a Teflon patch in case of an unavailable aortic patch: to do so, surgical complications, graft function, and patient survival were evaluated.Methods
During the period January 2009 to August 2016, 202 adult deceased-donor KTs were performed at our center. Group A (n = 27; reconstruction of multiple arteries) and Group B (n = 175; control group) were compared.Results
No differences were observed between the 2 groups in terms of early postoperative course, with no vascular complication observed in Group A. No vascular patch infections were reported, nor longer cold ischemia time rates. Similarly, long-term survival rates were similar between the 2 groups.Conclusions
The Teflon-patch arterial reconstruction technique appears to be safe and effective, with an acceptable balance of benefits and potential risks of using a prosthetic material. Studies based on larger series are needed to further validate this approach. 相似文献3.
4.
A. Montalto V. Piazza F. Albi R. Gherli C. Contento A. Palermo F. Musumeci 《Transplantation proceedings》2019,51(1):206-209
Background
Pump speed optimization in patients implanted with a ventricular assist device represents a major challenge during the follow-up period. We present our findings on whether combined invasive hemodynamic ramp tests and cardiopulmonary exercise testing (CPX) can help optimize patient management.Methods
Eighteen patients implanted with a HeartMate 3 (HM3) device underwent ramp tests with right heart catheterization (including central venous pressure [CVP], pulmonary artery pressure, pulmonary capillary wedge pressure [PCWP], and blood pressure) and echocardiography. Data were recorded at up to 4 speed settings. Speed changes were in steps of 200 revolutions/min (rpm). Evaluation of functional capacity by CPX was conducted according to the modified Bruce protocol.Results
Only 30% of patients had normal PCWPs at their original rpm settings. In going from lowest to highest speeds, cardiac output improved by 0.25 ± 0.35 L/min/step (total change, 1.28 ± 0.3 L/min), and PCWP decreased by 1.9 ± 0.73 mm Hg/step (total change, 6 ± 1.6 mm Hg). CVP and systolic blood pressure did not change significantly with rpm. The rpm assessment was adjusted based on test results to achieve CVPs and PCWPs as close to normal limits as possible, which was feasible in all patients. On CPX, all patients demonstrated good performance (peak VO2, 16.8 ± 3.5 mL/kg/min).Conclusion
Hemodynamic ramp testing provides an objective means of optimizing rpm, and has the potential to provide good exercise tolerance. 相似文献5.
6.
7.
8.
9.
D. Sforza G. Iaria L. Petagna A. Parente A. Anselmo F. Sergi S. Marzio F. Corrado S. Telli T.M. Manzia G. Tisone 《Transplantation proceedings》2019,51(1):140-142
Background
One daily dose of tacrolimus (QDT) improves adherence in kidney transplant (KT) recipients. A switch from twice-daily tacrolimus (BDT) to QDT showed similar efficacy and safety.Methods
The aim of our study was to demonstrate the long-term efficacy and safety of switching from BDT to QDT in KT recipients. Preliminary results have already been published. Forty-one patients (34 men and 7 women), mean age at KT of 43.9 ± 12.7 years, underwent a 1:1 dose switch from BDT to QDT; the mean time from KT to switch was 36.6 ± 16.1 months. In our study population, 4 patients received a living donor KT and 2 received a second allograft.Results
The mean follow-up was 86.8 ± 13 months from the switch and 126.2 ± 22.3 months from KT. Graft and patient survival rates were 90.2% and 95.1%, respectively. All patients maintained stable renal function during follow-up. During the first 3 months after the switch we observed a significant decrease in tacrolimus blood level (P = .0001). No significant differences were observed regarding tacrolimus dose before and after QDT introduction (P = not significant [NS]). Fourteen patients who stopped steroids under BDT treatment and 16 patients who stopped steroids after the switch are currently steroid-free.Conclusion
Our study showed safety and efficacy in switching from BDT to QDT. After early (<1 year) dose adjustment, tacrolimus blood levels remained stable throughout follow-up. Moreover, QDT represented a valid alternative for patients showing steroid side effects. 相似文献10.
Roberto Banfi Eleonora Pavone Rita Cerri Monica Menichetti 《Pharmacy World & Science》2007,29(4):400-403
In Italy mifepristone is not yet marketed. Gynaecologists in our hospital asked to use this medication as a less traumatic
method for voluntary abortions. We followed the standard procedure defined by the Italian Health Ministry (IMH) for purchasing
drugs from abroad but encountered several unexpected barriers. Starting from this case, this paper is aimed at identifying
these barriers which we found to be not only professional, but also ethical, religious and moral. 相似文献